Lipid-based systems with precipitation inhibitors as formulation approach to improve the drug bioavailability and/or lower its dose: a review

1 World Health Organization: WHO: Number of people over 60 years set to double by 2050; https://www.who.int/news/item/30-09-2015-who-number-of-people-over-60-years-set-to-double-by-2050-major-societal-changes-required; last access date September 23, 2023. Search in Google Scholar

2 R. J. Dagli and A. Sharma, Polypharmacy: A global risk factor for elderly people, J. Int. Oral Health 6(6) (2014) i–ii. Search in Google Scholar

3 A. Toma and O. Crişan, Green pharmacy – a narrative review, Clujul. Med. 91(4) (2018) 391–398; https://doi.org/10.15386/cjmed-1129 Search in Google Scholar

4 C. G. Daughton and I. S. Ruhoy, Lower-dose prescribing: Minimizing “side effects” of pharmaceuticals on society and the environment, Sci. Total. Environ. 15(443) (2013) 324–337; https://doi.org/10.1016/j.scitotenv.2012.10.092 Search in Google Scholar

5 J. B. Dressman and C. Reppas, In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs, Eur. J. Pharm. Sci. 1(11) (2000) 73–80; https://doi.org/10.1016/S0928-0987(00)00181-0 Search in Google Scholar

6 C. M. O’Driscoll and B. T. Griffin, Biopharmaceutical challenges associated with drugs with low aqueous solubility – The potential impact of lipid-based formulations, Adv. Drug Deliv. Rev. 60(6) (2008) 617–624; https://doi.org/10.1016/j.addr.2007.10.012 Search in Google Scholar

7 P. Kocbek, Nanosuspenzije – aktualni nanotehnološki pristop za izdelavo farmacevtskih oblik s težko topnimi učinkovinami?, Farm. Vestn. 67 (2016) 296–302; https://www.sfd.si/wp-content/uploads/sfd/datoteke/kocbek.pdf Search in Google Scholar

8 N. Atakan and C. Erdem, The efficacy, tolerability and safety of a new oral formulation of Sandimmun^®-Sandimmun Neoral^® in severe refractory atopic dermatitis, J. Eur. Acad. Dermatol. Venereol. 11(3) (1998) 240–246; https://doi.org/10.1111/j.1432-2277.1994.tb01363.x Search in Google Scholar

9 P. S. L. Ruíz, M. R. Serafini, I. A. Alves and D. M. A. Novoa, Recent progress in self-emulsifying drug delivery systems: A systematic patent review (2011–2020), Crit. Rev. Ther. Drug Carr. Syst. 39(2) (2022) 1–77; https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2021038490 Search in Google Scholar

10 A. Tan, S. Rao and C. A. Prestidge, Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance, Pharm. Res. 30(12) (2013) 2993–3017; https://doi.org/10.1007/s11095-013-1107-3 Search in Google Scholar

11 I. Maji, S. Mahajan, A. Sriram, P. Medtiya, R. Vasave and D. K. Khatri, Solid self emulsifying drug delivery system: Superior mode for oral delivery of hydrophobic cargos, J. Control. Release 337 (2021) 646–660; https://doi.org/10.1016/j.jconrel.2021.08.013 Search in Google Scholar

12 M. Krstić, M. Popović, V. Dobričić and S. Ibrić, Influence of solid drug delivery system formulation on poorly water-soluble drug dissolution and permeability, Molecules 20(8) (2015) 14684–14698; https://doi.org/10.3390/molecules200814684 Search in Google Scholar

13 H. Park, E. S. Ha and M. S. Kim, Current status of supersaturable self-emulsifying drug delivery systems, Pharmaceutics 12(4) (2020) Article ID 365 (57 pages); https://doi.org/10.3390/pharmaceutics12040365 Search in Google Scholar

14 K. Rajpoot, M. Tekade, V. Pandey, S. Nagaraja, S. R. Youngren-Ortiz and R. K. Tekade, Self-micro-emulsifying drug-delivery system: ongoing challenges and future ahead, Drug Deliv. Syst. (2020) 393–454; https://doi.org/10.1016/B978-0-12-814487-9.00009-0 Search in Google Scholar

15 R. Holm, M. Kuentz, A. R. Ilie-Spiridon and B. T. Griffin, Lipid based formulations as supersaturating oral delivery systems: From current to future industrial applications, Eur. J. Pharm. Sci. 189(1) (2023) Article ID 106556 (23 pages); https://doi.org/10.1016/j.ejps.2023.106556 Search in Google Scholar

16 P. Gao, B. D. Rush, W. P. Pfund, T. Huang, J. M. Bauer, W. Morozowich, M.-S. Kuo and M. J. Hageman, Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability, J. Pharm. Sci. 92(12) (2003) 2386–2398; https://doi.org/10.1002/jps.10511 Search in Google Scholar

17 P. Gao and W. Morozowich, Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs, Expert Opin. Drug Deliv. 3(1) (2006) 97–110; https://doi.org/10.1517/17425247.3.1.97 Search in Google Scholar

18 O. M. Feeney, M. F. Crum, C. L. McEvoy, N. L. Trevaskis, H. D. Williams, C. W. Pouton, William N. Charman, C. A. S. Bergström and C. J. H. Porter, 50 years of oral lipid-based formulations: Provenance, progress and future perspectives, Adv. Drug Deliv. Rev. 101 (2016) 167–194; https://doi.org/10.1016/j.addr.2016.04.007 Search in Google Scholar

19 C. J. H. Porter, N. L. Trevaskis and W. N. Charman, Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs, Nat. Rev. Drug Discov. 6(3) (2007) 231–48; https://doi.org/10.1038/nrd2197 Search in Google Scholar

20 K. Čerpnjak, A. Zvonar, M. Gašperlin and F. Vrečer, Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs, Acta Pharm. 63(4) (2013) 427–445; https://doi.org/10.2478/acph-2013-0040 Search in Google Scholar

21 A. Zvonar, K. Berginc, A. Kristl and M. Gašperlin, Microencapsulation of self-microemulsifying system: Improving solubility and permeability of furosemide, Int. J. Pharm. 388(1–2) (2010) 151–158; https://doi.org/10.1016/j.ijpharm.2009.12.055 Search in Google Scholar

22 A. Zvonar, B. Rozman, M. Bešter Rogač and M. Gašperlin, The influence of microstructure on celecoxib release from a pharmaceutically applicable system: Mygliol 812^®/Labrasol^®/Plurol Oleique^®/Water Mixtures, Acta Chim. Slov. 56(1) (2009) 131–138; http://acta.chem-soc.si/56/56-1-131.pdf Search in Google Scholar

23 R. N. Gursoy and S. Benita, Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs, Biomed. Pharmacother. Biomed. Pharmacother. 58(3) (2004) 173–182; https://doi.org/10.1016/j.biopha.2004.02.001 Search in Google Scholar

24 J. Chamieh, A. Domènech Tarrat, C. Doudou, V. Jannin, F. Demarne and H. Cottet, Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analysis, Int. J. Pharm. 559 (2019) 228–234; https://doi.org/10.1016/j.ijpharm.2019.01.039 Search in Google Scholar

25 J. Griesser, G. Hetényi, C. Federer, C. Steinbring, H. Ellemunter and K. Niedermayr, Highly mucus permeating and zeta potential changing self-emulsifying drug delivery systems: A potent gene delivery model for causal treatment of cystic fibrosis, Int. J. Pharm. 557 (2019) 124–134; https://doi.org/10.1016/j.ijpharm.2018.12.048 Search in Google Scholar

26 C. W. Pouton, Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system, Eur. J. Pharm. Sci. 29(3) (2006) 278–287; https://doi.org/10.1016/j.ejps.2006.04.016 Search in Google Scholar

27 M. Krstić, Đ. Medarević, J. Đuriš and S. Ibrić, Self-nanoemulsifying drug delivery systems (SNEDDS) and self-microemulsifying drug delivery systems (SMEDDS) as lipid nanocarriers for improving dissolution rate and bioavailability of poorly soluble drugs, Lipid Nanocarriers Drug Targeting (2018) 473–508; https://doi.org/10.1016/B978-0-12-813687-4.00012-8 Search in Google Scholar

28 N. Anton and T. F. Vandamme, Nano-emulsions and micro-emulsions: clarifications of the critical differences, Pharm. Res. 28(5) (2011) 978–985; https://doi.org/10.1007/s11095-010-0309-1 Search in Google Scholar

29 C. W. Pouton and C. J. H. Porter, Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies, Adv. Drug Deliv. Rev. 60(6) (2008) 625–637; https://doi.org/10.1016/j.addr.2007.10.010 Search in Google Scholar

30 U. Goyal, R. Arora and G. Aggarwal, Formulation design and evaluation of a self-microemulsifying drug delivery system of lovastatin, Acta Pharm. 62(3) (2012) 357–370; https://doi.org/10.2478/v10007-012-0022-1 Search in Google Scholar

31 R. Jakki, M. A. Syed, P. Kandadi and K. Veerabrahma, Development of a self-microemulsifying drug delivery system of domperidone: In vitro and in vivo characterization, Acta Pharm. 63(2) (2013) 241–251; https://doi.org/10.2478/acph-2013-0013 Search in Google Scholar

32 C. J. H. Porter, C. W. Pouton, J. F. Cuine and W. N. Charman, Enhancing intestinal drug sulubilization using lipid-based delivery systems, Adv. Drug Deliv. Rev. 60 (2008) 673–691; https://doi.org/10.1016/j.addr.2007.10.014 Search in Google Scholar

33 H. D. Williams, N. L. Trevaskis, Y. Y. Yeap, M. U. Anby, C. W. Pouton and C. J. H. Porter, Lipid-based formulations and drug supersaturation: Harnessing the unique benefits of the lipid digestion/absorption pathway, Pharm. Res. 30(12) (2013) 2976–2992; https://doi.org/10.1007/s11095-013-1126-0 Search in Google Scholar

34 L. C. Alskär, J. Keemink, J. Johannesson and C. J. H. Porter, Impact of drug physicochemical properties on lipolysis-triggered drug supersaturation and precipitation from lipid-based formulations, Mol. Pharm. 15(10) (2018) 4733–4744; https://doi.org/10.1021/acs.molpharmaceut.8b00699 Search in Google Scholar

35 Y. Y. Yeap, N. L. Trevaskis and C. J. H. Porter, Lipid absorption triggers drug supersaturation at the intestinal unstirred water layer and promotes drug absorption from mixed micelles, Pharm. Res. 30(12) (2013) 3045–3058; https://doi.org/10.1007/s11095-013-1104-6 Search in Google Scholar

36 C. Stillhart and M. Kuentz, Trends in the assessment of drug supersaturation and precipitation in vitro using lipid-based delivery systems, J. Pharm. Sci. 105(9) (2016) 2468–2476; https://doi.org/10.1016/j.xphs.2016.01.010 Search in Google Scholar

37 J. Brouwers, M. E. Brewster and P. Augustijns, Supersaturating drug delivery systems: The answer to solubility-limited oral bioavailability?, J. Pharm. Sci. 98(8) (2009) 2549–2572; https://doi.org/10.1002/jps.21650 Search in Google Scholar

38 D. B. Warren, H. Benameur, C. W. Pouton and C. J. H. Porter, Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility, J. Drug Target. 18(10) (2010) 704–731; https://doi.org/10.3109/1061186X.2010.525652 Search in Google Scholar

39 N. Rodríguez-Hornedo, S. J. Nehm, K. F. Seefeldt, Y. Pagan-Torres and C. J. Falkiewicz, Reaction crystallization of pharmaceutical molecular complexes, Mol. Pharm. 3(3) (2006) 362–367; https://doi.org/10.1021/mp050099m Search in Google Scholar

40 V. I. Kalikmanov, Classical Nucleation Theory, in Nucleation Theory, Chapter 3, Springer, Dordrecht 2013, pp. 17–41; https://doi.org/10.1007/978-90-481-3643-8 Search in Google Scholar

41 L. Lindfors, S. Forssén, J. Westergren and U. Olsson, Nucleation and crystal growth in supersatu-rated solutions of a model drug, J. Colloid Interface Sci. 325(2) (2008) 404–413; https://doi.org/10.1016/j.jcis.2008.05.034 Search in Google Scholar

42 P. B. Myrdal and S. H. Yalkowsky, Solubilization of Drugs in Aqueous Media, Encyclopedia of Pharmaceutical Science and Technology, Six Volume Set, 4th ed., CRC Press, 2013. Search in Google Scholar

43 D. J. Pricea, F. Ditzingerc, N. J. Koehle and S. Jankovic, Approaches to increase mechanistic understanding and aid in the selection of precipitation inhibitors for supersaturating formulations – a PEARRL review, J. Pharm. Pharmacol. 71 (2019) 483–509; https://doi.org/10.1111/jphp.12927 Search in Google Scholar

44 H. R. Guzmán, M. Tawa, Z. Zhang, P. Ratanabanangkoon, P. Shaw, C. R. Gardner, H. Chen, J.-P. Moreau, O. Almarsson and J. F. Remenar, Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations, J. Pharm. Sci. 96(10) (2007) 2686–2702; https://doi.org/10.1002/jps.20906 Search in Google Scholar

45 H. R. Guzmán, M. Tawa, Z. Zhang, P. Ratanabanangkoon, P. Shaw, P. Mustonen, C. Gardner, H. Chen, J.-P. Moreau, O. Almarsson and J. Remenar, Spring and parachute approach to designing solid celecoxib formulations having enhanced oral absorption, AAPS J. 6 (2004) T2189. Search in Google Scholar

46 W. H. Song, J. H. Park, D. W. Yeom, B. K. Ahn, K. M. Lee, S. G. Lee, H. S. Woo and Y. W. Choi, Enhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system ( S-SEDDS) formulation, Arch. Pharm. Res. 36(1) (2013) 69–78; https://doi.org/10.1007/s12272-013-0011-z Search in Google Scholar

47 D. Kashchiev and G. M. van Rosmalen, Review: Nucleation in solutions revisited, Cryst. Res. Technol. 38(7–8) (2003) 555–574; https://doi.org/10.1002/crat.200310070 Search in Google Scholar

48 N. A. Elkasabgy, Ocular supersaturated self-nanoemulsifying drug delivery systems (S-SNEDDS) to enhance econazole nitrate bioavailability, Int. J. Pharm. 460(1–2) (2014) 33–44; https://doi.org/10.1016/j.ijpharm.2013.10.044 Search in Google Scholar

49 H. D. Williams, N. L. Trevaskis, Y. Y. Yeap, M. U. Anby, C. W. Pouton and C. J. H. Porter, Lipid-based formulations and drug supersaturation: Harnessing the unique benefits of the lipid digestion/absorption pathway, Pharm. Res. 30(12) (2013) 2976–2992; https://doi.org/10.1007/s11095-013-1126-0 Search in Google Scholar

50 H. D. Williams, P. Sassene, K. Kleberg, M. Calderone, A. Igonin, E. Jule, J. Vertommen, R. Blundell, H. Benameur, A. Müllertz, C. W. Pouton and C. J. H. Porter, Toward the establishment of standardized in vitro tests for lipid- based formulations, Part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations, Pharm. Res. 30(12) (2013) 3059–3076; https://doi.org/10.1007/s11095-013-1038 Search in Google Scholar

51 H. D. Williams, M. U. Anby, P. Sassene, K. Kleberg, J. C. Bakala-N’Goma, M. Calderone, V. Jannin, A. Igonin, A. Partheil, D. Marchaud, E. Jule, J. Vertommen, M. Maio, R. Blundell, H. Benameur, F. Carrière, A. Müllertz, C. W. Pouton and C. J. H. Porter, Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion, Mol. Pharm. 9(11) (2012) 3286–3300; https://doi.org/10.1021/mp300331z Search in Google Scholar

52 P. Gao, B. D. Rush, W. P. Pfund, T. Huang, J. M. Bauer, W. Morozowich, M.-S. Kuo and M. J. Hageman, Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability, J. Pharm. Sci. 92 (12) (2003) 2386–2398; https://doi.org/10.1002/jps.10511 Search in Google Scholar

53 R. B. Chavan, R. Thipparaboina, D. Kumarab and N. R. Shastri, Evaluation of the inhibitory potential of HPMC, PVP and HPC polymers on nucleation and crystal growth, RSC Adv. 6 (2016) 77569–77576; https://pubs.rsc.org/en/content/articlelanding/2016/ra/c6ra19746a Search in Google Scholar

54 E. J. A. Suys, D. K. Chalmers, P. C. W. Pouton and C. J. H. Porter, Polymeric precipitation inhibitors promote fenofibrate supersaturation and enhance drug absorption from a type IV lipid-based formulation, Mol. Pharm. 15(6) (2018) 2355–2371; https://doi.org/10.1021/acs.molpharmaceut.8b00206 Search in Google Scholar

55 S. Xu and W. G. Dai, Drug precipitation inhibitors in supersaturable formulations, Int. J. Pharm. 453(1) (2013) 36–43; https://doi.org/10.1016/j.ijpharm.2013.05.013 Search in Google Scholar

56 J. C. DiNunzio, D. A. Miller, W. Yang, J. W. McGinity and R. O. Williams, Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole, Mol. Pharm. 5(6) (2008) 968–980; https://doi.org/10.1021/mp800042d Search in Google Scholar

57 D. B. Warren, C. A. S. Bergström, H. Benameur, C. W. Pouton and C. J. H. Porter, Evaluation of the structural determinants of polymeric precipitation inhibitors using solvent shift methods and principle component analysis, Mol. Pharm. 10(8) (2013) 2823–2848; https://doi.org/10.1021/mp300576u Search in Google Scholar

58 P. Gao, A. Akrami, F. Alvarez, J. Hu, L. Li, C. Ma and S. Surapaneni, Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption, J. Pharm. Sci. 98(2) (2009) 516–528; https://doi.org/10.1002/jps.21451 Search in Google Scholar

59 P. J. Sassene, M. M. Knopp, J. Z. Hesselkilde, V. Koradia, A. Larsen, T. Rades and A. Müllertz, Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate, J. Pharmy. Sci. 99(12) (2010) 4982–4991; https://doi.org/10.1002/jps.22226 Search in Google Scholar

60 J. Mandić, A. Zvonar Pobirk, F. Vrečer and M. Gašperlin, Overview of solidification techniques for self-emulsifying drug delivery systems from industrial perspective, Int. J. Pharm. 533(2) (2017) 335–345; https://doi.org/10.1016/j.ijpharm.2017.05.036 Search in Google Scholar

61 J. Mandić, I. Kosmač, M. Kovačević, B. Hodnik, Ž. Hodnik, F. Vrečer, M. Gašperlin, B. Perissutti and A. Zvonar Pobirk, Evaluation of solid carvedilol-loaded SMEDDS produced by the spray drying method and a study of related substances, Int. J. Pharm. 605 (2021) Article ID 120783 (14 pages); https://doi.org/10.1016/j.ijpharm.2021.120783 Search in Google Scholar

62 P. Mura, M. Valleri, M. Cirri and N. Mennini, New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs, Pharm. Dev. Technol. 17(3) (2012) 277–284; https://doi.org/10.3109/10837450.2010.535825 Search in Google Scholar

63 K. Čerpnjak, A. Zvonar, F. Vrečer and M. Gašperlin, Development of a solid self-microemulsifying drug delivery system (SMEDDS) for solubility enhancement of naproxen, Drug Dev. Ind. Pharm. 41(9) (2015) 1548–1557; https://doi.org/10.3109/03639045.2014.971031 Search in Google Scholar

64 M. Kovačević, I. German Ilić, K. Bolko Seljak and A. Zvonar Pobirk, High-shear wet granulation of SMEDDS based on mesoporous carriers for improved carvedilol solubility, Pharmaceutics 14(10) (2022) Article ID 2077 (21 pages); https://doi.org/10.3390/pharmaceutics14102077 Search in Google Scholar

65 R. B. Chavan, S. Rathi, V. G. S. S. Jyothi and N. R. Shastri, Cellulose based polymers in development of amorphous solid dispersions, Asian J. Pharm. Sci. 14(3) (2019) 248–264; https://doi.org/10.1016/j.ajps.2018.09.003 Search in Google Scholar

66 G. Singh and R. S. Pai, In vitro and in vivo performance of supersaturable self-nanoemulsifying system of trans-resveratrol, Artif. Cells Nanomed. Biotechnol. 44(2) (2016) 510–516; https://doi.org/10.3109/21691401.2014.966192 Search in Google Scholar

67 K. Jo, H. Kim, P. Khadka, T. Jang, S. J. Kim, S. H. Hwang and J. Lee, Enhanced intestinal lymphatic absorption of saquinavir through supersaturated self-microemulsifying drug delivery systems, Asian J. Pharm. Sci. 15(3) (2018) 336–346; https://doi.org/10.1016/j.ajps.2018.11.009 Search in Google Scholar

68 S. F. Albaidhani and A. A Hussein, Preparation and evaluation of solid supersaturable self- nanoemulsifying drug delivery system of candesartan cilexetil, J. Pharm. Sci. Res. 11(10) (2019) 859–868; https://jpsr.pharmainfo.in/Documents/Volumes/vol11issue03/jpsr11031936.pdf Search in Google Scholar

69 S. L. Raghavan, A. Trividic, A. F. Davis and J. Hadgraft, Crystallization of hydrocortisone acetate: influence of polymers, Int. J. Pharm. 212(2) (2001) 213–221; https://doi.org/10.1016/s0378-5173(00)00610-4 Search in Google Scholar

70 N. T. Tung, C. S. Tran, H. A. Nguyen, T. D. Nguyen, S. C. Chi, D. V. Pham, Q.-D. Bui and X. H. Ho, Formulation and biopharmaceutical evaluation of supersaturatable self-nanoemulsifying drug delivery systems containing silymarin, Int. J. Pharm. 555 (2019) 63–76; https://doi.org/10.1016/j.ijpharm.2018.11.036 Search in Google Scholar

71 M. U. Anby, H. D. Williams, M. McIntosh, H. Benameur, G. A. Edwards, C. W. Pouton and C. J. H. Poter, Lipid digestion as a trigger for supersaturation: Evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems, Mol. Pharm. 9(7) (2012) 2063–2079; https://doi.org/10.1021/mp300164u Search in Google Scholar

72 D. R. Lee, M. J. Ho, Y. W. Choi and M. J. Kang, A polyvinylpyrrolidone-based supersaturable self-emulsifying drug delivery system for enhanced dissolution of cyclosporine A, Polymers 9(4) (2017) Article ID 124 (11 pages); https://doi.org/10.3390/polym9040124 Search in Google Scholar

73 S. Bandyopadhyay, O. P. Katare and B. Singh, Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters, Expert Opin. Drug Deliv. 11(4) (2014) 479–492; https://doi.org/10.1517/17425247.2014.877885 Search in Google Scholar

74 J. Mandić, V. Pirnat, M. Luštrik, I. German Ilić, F. Vrečer, M. Gašperlin and A. Zvonar Pobirk, Solidification of SMEDDS by fluid bed granulation and manufacturing of fast drug release tablets, Int. J. Pharm. 583 (2020) Article ID 119377 (14 pages); https://doi.org/10.1016/j.ijpharm.2020.119377 Search in Google Scholar

75 M. Kovačević, A. Zvonar Pobirk and I. German Ilić, The effect of polymeric binder type and concentration on flow and dissolution properties of SMEDDS loaded mesoporous silica-based granules, Eur. J. Pharm. Sci. 193 (2024) Article ID 106582 (11 pages); https://doi.org/10.1016/j.ejps.2023.106582 Search in Google Scholar

76 Aquasolve™ hydroxypropylmethyl cellulose acetate succinate, Physical and chemical properties handbook, Ashland, 2016, pp. 12-14. https://www.ashland.com/file_source/Ashland/Industries/Pharmaceutical/Links/PC-12624.6_AquaSolve_HPMCAS_Physical_Chemical_Properties.pdf Search in Google Scholar

77 I. Ghosh, J. Snyder, R. Vippagunta, M. Alvine, R. Vakil, W. Q. Tong and S. Vippagunta, Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder, Int. J. Pharm. 419(1–2) (2011) 12–19; https://doi.org/10.1016/j.ijpharm.2011.05.073 Search in Google Scholar

78 Z. Q. Chen, Y. Liu, J. H. Zhao, L. Wang and N. P. Feng, Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system, Int. J. Nano-medicine 7 (2012) 1115–1125; https://doi.org/10.2147/IJN.S28761 Search in Google Scholar

79 T. Reintjes, Solubility Enhancement with BASF Pharma Ppolymers, Solubilizer Compendium, BASF, Ludwigshafen 2011, pp. 67–72. Search in Google Scholar

80 V. Buhler, Kollidon^® Polyvinlylpyrrolidone Excipients for the Pharmaceutical Industry, 9th ed., BASF, Ludwigshafen 2008, pp. 22–32; https://www.pharmacompass.com/pAssets/pdf/edqm/application/gmpkollidon.pdf Search in Google Scholar

81 L. Lindfors, S. Forssén, J. Westergren and U. Olsson, Nucleation and crystal growth in supersatu-rated solutions of a model drug, J. Colloid Interface Sci. 325(2) (2008) 404–413; https://doi.org/10.1016/j.jcis.2008.05.034 Search in Google Scholar

82 M. Patki and K. Patel, Development of a solid supersaturated self-nanoemulsifying preconcentrate (S-superSNEP) of fenofibrate using dimethylacetamide and a novel co-processed excipient, Drug Dev. Ind. Pharm. 45(3) (2019) 405–414; https://doi.org/10.1080/03639045.2018.1546311 Search in Google Scholar

83 D. H. Lee, D. W. Yeom, Y. S. Song, H. R. Cho, Y. S. Choi, M. J. Kang and Y. W. Choi, Improved oral absorption of dutasteride via Soluplus^® -based supersaturable self-emulsifying drug delivery system (S-SEDDS), Int. J. Pharm. 478(1) (2015) 341–347; https://doi.org/10.1016/j.ijpharm.2014.11.060 Search in Google Scholar

84 G. Quan, B. Niu, V. Singh, Y. Zhou, C. Y. Wu, X. Pan and C. Wu, Supersaturable solid self-micro-emulsifying drug delivery system: precipitation inhibition and bioavailability enhancement, Int. J. Nanomedicine 12 (2017) 8801–8811; https://doi.org/10.2147/IJN.S149717 Search in Google Scholar

85 D. R. Lee, H. J. Jung, H. R. Cho, J. S. Park, S. H. Yoon, Y. S. Choi, Y. W. Choi, C. Oh and M. J. Kang, Enhanced dissolution and oral absorption of tacrolimus by supersaturable self-emulsifying drug delivery system, Int. J. Nanomedicine 11 (2016) 1109–1117; https://doi.org/10.2147/IJN.S102991 Search in Google Scholar

86 R. B. Chavan, S. R. Modi and A. K. Bansal, Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib, Int. J. Pharm. 495(1) (2015) 374–384; https://doi.org/10.1016/j.ijpharm.2015.09.011 Search in Google Scholar

87 S. Javed, K. Kohli and M. Ali, Reassessing bioavailability of silymarin, Altern. Med. Rev. 16(3) (2011) 239–249. Search in Google Scholar

88 D. J. Shin, B. R. Chae, Y. T. Goo Y, H. Y. Yoon, C. H. Kim, S. I. Sohn S, D. Oh, A. Lee, S. H. Song and Y. W. Choi, Improved dissolution and oral bioavailability of valsartan using a solidified supersaturable self-microemulsifying drug delivery system containing Gelucire^® 44/14, Pharmaceutics 11(2) (2019) Article ID 58 (19 pages); https://doi.org/10.3390/pharmaceutics11020058 Search in Google Scholar

89 D. Singh, A. P. Singh, D. Singh, A. K. Kesavan, A. K. Tiwary and N. Bedi, Polymeric precipitation inhibitor-based solid supersaturable SMEDD formulation of canagliflozin: Improved bioavailability and anti-diabetic activity, J. Pharm. Innov. 16 (2021) 317–336; https://doi.org/10.1007/s12247-020-09445-1 Search in Google Scholar

90 Evonik Eudragit Brochure.pdf; https://www.scribd.com/document/360752511/Evonik-Eudragit-Brochure; last access date September 26, 2023. Search in Google Scholar

91 S. Takemura, H. Kondo, S. Watanabe, K. Sako, K. Ogawara and K. Higaki Aminoalkylmethacrylate copolymer E improves oral bioavailability of YM466 by suppressing drug–bile interaction, J. Pharm. Sci. 102(9) (2013) 3128–3135; https://doi.org/10.1002/jps.23484 Search in Google Scholar

92 M. E. Brewster, R. Vandecruys, J. Peeters, P. Neeskens, G. Verreck and T. Loftsson, Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions, Eur. J. Pharm. Sci. 34(2–3) (2008) 94–103; https://doi.org/10.1016/j.ejps.2008.02.007 Search in Google Scholar

93 S. S. Buddhadev, K. C. Garalaa, S. Saisivam, M. Rahamathulla, M. M. Ahmed, S. A. Farhana and I. Pasha, Quality by design aided self-nano emulsifying drug delivery systems development for the oral delivery of benidipine: Improvement of biopharmaceutical performance, Drug Deliv. 31(1) (2024) Article ID 2288801 (19 pages); https://doi.org/10.1080/10717544.2023.2288801 Search in Google Scholar

94 C. Jin, F. Wu, Y. Hong, L. Shen, X. Lin, L. Zhao and F. Feng, Updates on applications of low-viscosity grade hydroxypropyl methylcellulose in coprocessing for improvement of physical properties of pharmaceutical powders, Carbohydr. Polym. 311 (2023) Article ID 120731 (12 pages); https://doi.org/10.1016/j.carbpol.2023.120731 Search in Google Scholar

95 Z. Yang, A. Chai, P. Zhou, P. Li and Y. Yang, Effect of polymer rigidity on the phase behaviour of polymer adsorption on to planar surface, Biosci. Rep. 36(6) (2016) Article ID e00415 (10 pages); https://doi.org/10.1042/BSR20160220 Search in Google Scholar

96 J. Bevernage, J. Brouwers, M. E. Brewster and P. Augustijns, Evaluation of gastrointestinal drug supersaturation and precipitation: Strategies and issues, Int. J. Pharm. 453(1) (2013) 25–35; https://doi.org/10.1016/j.ijpharm.2012.11.026 Search in Google Scholar

97 N. Zhang, W. Zhang, Y. Jin and D. qin Quan, Studies on preparation of carbamazepine (CBZ) supersaturatable self-microemulsifying (S-SMEDDS) formulation and relative bioavailability in beagle dogs, Pharm. Dev. Technol. 16(4) (2011) 415–421; https://doi.org/10.3109/10837451003774419 Search in Google Scholar

98 A. R. Ilie, B. T. Griffin, M. Vertzoni, M. Kuentz, R. Kolakovic, A. Prudic-Paus, A. Malash, H. Bohets and J. Herman, Exploring precipitation inhibitors to improve in vivo absorption of cinnarizine from supersaturated lipid-based drug delivery systems, Eur. J. Pharm. Sci. 159 (2021) 105691; https://doi.org/10.1016/j.ejps.2020.105691 Search in Google Scholar

99 Y. Tanaka, A. Kawakami, A. Nanimatsu, M. Horio, J. Matsuoka, T. Wada, S. Kasaoka and H. Yoshikawa, In vivo evaluation of supersaturation/precipitation/re-dissolution behavior of cinnarizine, a lipophilic weak base, in the gastrointestinal tract: the key process of oral absorption, Eur. J. Pharm. Sci. 96 (2017) 464–471; https://doi.org/10.1016/j.ejps.2016.10.023 Search in Google Scholar

100 P. Gao, M. E. Guyton, T. Huang, J. M. Bauer, K. J. Stefanski and Q. Lu, Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations, Drug Dev. Ind. Pharm. 30(2) (2004) 221–229; https://doi.org/10.1081/ddc-120028718 Search in Google Scholar

101 Y. Seto, C. Morizane, K. Ueno, H. Sato and S. Onoue, Supersaturable self-emulsifying drug delivery system of krill oil with improved oral absorption and hypotriglyceridemic function, J. Agric. Food Chem. 66(21) (2018) 5352–5358; https://doi.org/10.1021/acs.jafc.8b00693 Search in Google Scholar

102 M. Ogino, K. Yakushiji, H. Suzuki, K. Shiokawa, H. Kikuchi, Y. Seto, H. Sato and S. Onoue, Enhanced pharmacokinetic behavior and hepatoprotective function of ginger extract-loaded supersaturable self-emulsifying drug delivery systems, J. Funct. Foods 40 (2018) 156–163; https://doi.org/10.1016/j.jff.2017.08.035 Search in Google Scholar

103 Y. T. Goo, S. H. Song, D. W. Yeom, B. R. Chae, H. Y. Yoon, C. H. Kim, S. Y. Park, T. H. Kang, S. Lee and Y. W. Choi, Enhanced oral bioavailability of valsartan in rats using a supersaturable self-- microemulsifying drug delivery system with P-glycoprotein inhibitors, Pharm. Dev. Technol. 25(2) (2020) 178–86; https://doi.org/10.1080/10837450.2019.1683749 Search in Google Scholar

104 D. W. Yeom, B. R. Chae, J. H. Kim, J. S. Chae, D. J. Shin, C. H. Kim, S. R. Kim, J. H. Choi, S. H. Song, D. Oh, S. I. Sohn and Y. W. Choi, Solid formulation of a supersaturable self-microemulsifying drug delivery system for valsartan with improved dissolution and bioavailability, Oncotarget 8(55) (2017) 94297–94316; https://doi.org/10.18632/oncotarget.21691 Search in Google Scholar

105 W. T. Aung and V. Boonkanokwong, Impact of polymers as precipitation inhibitors on physico-chemical properties of spray-dried astaxanthin-loaded self-microemulsifying delivery systems, Key Eng. Mater. 914 (2022) 15–21.; https://doi.org/10.4028/p-8mdb16 Search in Google Scholar